Improve the value proposition of G6PD testing by considering otherclinical benefits (not only as part of malaria case management) such asaverting exposure to other oxidative agents, improved management of neonatalhyperbilirubinaemia in offspring and averting kernicterus. This evidence concerns the gene G6PD and kernicterus.